A silent threat looms: India's fight against HIV faces a critical challenge, and it's one we can't afford to ignore. But here's the core issue: delays in early HIV testing during pregnancy are putting both mothers and newborns at risk. Let's dive deeper.
Dr. Pankhuri Gautam, a Senior Consultant in Obstetrics & Gynecology at Cocoon Hospital, Jaipur, stresses that early HIV testing is absolutely crucial for safe deliveries. Despite advancements, the gap in antenatal HIV screening persists, exposing mothers and babies to avoidable dangers.
Dr. Gautam highlights that medical science offers near-total control over mother-to-child transmission. With early interventions, transmission rates can drop below 2%. The real problem isn't the lack of treatment; it's the delay in testing.
Early screening is the most critical step: HIV often progresses silently for years, making timely diagnosis during pregnancy essential. Dr. Gautam emphasizes that many women are unaware of their HIV status. That's why testing at the first antenatal visit and again in the third trimester is critical.
Early detection allows doctors to start antiretroviral therapy (ART) immediately, rapidly lowering the mother's viral load to undetectable levels. When the viral load is controlled, women can safely undergo vaginal deliveries without increasing the risk to the infant.
Late detection, however, significantly narrows treatment opportunities. Transmission can occur during pregnancy, labor, delivery, and breastfeeding. According to data from the National AIDS Control Organisation (NACO), 25–30% of HIV-positive pregnant women are diagnosed for the first time during pregnancy. This highlights gaps in routine screening and persistent stigma.
Zero transmission is possible: Dr. Gautam emphasizes that eliminating mother-to-child HIV transmission (MTCT) is an achievable public health goal. Countries in Europe, Africa, and Southeast Asia have demonstrated that near-zero transmission is possible with consistent protocols—universal antenatal testing, early ART, planned delivery methods, infant prophylaxis within 6–12 hours, and clear breastfeeding guidance.
India already has the clinical ecosystem to replicate these outcomes. “The capability exists. What we need is universal and timely screening, every single time,” she stresses.
Early screening allows personalized care at every step, from the first antenatal consultation to postpartum follow-up. It helps in planning labor safely, administering infant prophylaxis on time, managing infection control at delivery, and offering clear breastfeeding guidance.
Early diagnosis also reduces emotional distress among families and ensures long-term adherence to ART for mothers.
Protocols that hospitals must strengthen: To support India's goal of eliminating mother-to-child transmission, Dr. Gautam highlights key clinical steps all maternity centers must follow:
- Universal first-trimester HIV screening, regardless of risk factors
- Repeat HIV test in the third trimester to detect new infections
- Immediate ART initiation within 24 hours of diagnosis
- Delivery planning based on updated viral load levels, supporting safe vaginal or cesarean birth
- Infant prophylaxis within 6–12 hours of birth, aligned with national guidelines
- Stigma-free counseling on breastfeeding and postpartum follow-up
“Hospitals must normalize HIV screening as a standard antenatal procedure, not as a test triggered by risk or suspicion. That shift alone can protect thousands of babies,” Dr Gautam said.
So, what do you think? Are we doing enough to prioritize early HIV testing during pregnancy? Do you agree with the protocols Dr. Gautam suggests? Share your thoughts in the comments below – let's start a conversation!
